You are here

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Fountain Valley, California, 92708 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pulmonary Arterial Hypertension, Pulmonary Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
16-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Current diagnosis of symptomatic pulmonary arterial hypertension (PAH) classified by
one of the following: idiopathic arterial hypertension (IPAH), primary pulmonary
hypertension (PPH), familial pulmonary arterial hypertension (FPAH) or pulmonary
arterial hypertension (PAH) associated with connective tissue diseases. Has WHO
functional class III symptoms.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous exposure to an endothelin receptor antagonist (ETRA) such as sitaxsentan,
bosentan or ambrisentan.

NCT00795639
Pfizer
Terminated
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Pulmonary Hypertension
NCT00454207
All Genders
16+
Years
Multiple Sites
PPHN, Persistent Pulmonary Hypertension of the Newborn, Hypoxic Respiratory Failure
NCT01069861
All Genders
0+
Years
London,
Pulmonary Arterial Hypertension, Pulmonary Hypertension
NCT00795639
All Genders
16+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now